TherapeuticsMD Inc (NASDAQ:TXMD)

6.40
Delayed Data
As of May 25
 +0.31 / +5.09%
Today’s Change
3.83
Today|||52-Week Range
7.01
+5.96%
Year-to-Date

Today’s Trading

Previous close6.09
Today’s open6.10
Day’s range6.10 - 6.52
Volume4,531,761
Average volume (3 months)2,199,791
Market cap$1.3B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+19.57%
Earnings growth (this year)-39.81%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)-13.32%
P/E ratioNM
Price/Sales73.99
Price/Book9.90

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...-0.10-0.21%
ESPREsperion Therapeutic...-0.15-0.40%
BHVNBiohaven Pharmaceuti...-0.04-0.12%
FWPForward Pharma A/S-0.19-6.11%
Data as of 4:02pm ET, 05/25/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$16.8M
Annual profit (last year)-$76.9M
Net profit margin-458.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts